Modern Practice Podcast
Modern Practice Podcast
Vizient Medical Leadership Team
The promise and limitations of expedited approval, Part 1
11 minutes Posted Mar 9, 2023 at 3:00 pm.
] Vaccine approval path before and after COVID
] Rationale for accelerated approval; reducing preapproval research
] Examples of expedited approval recently – reducing the eight-year duration
] Rundown of various approval routes
0:00
11:58
Download MP3
Show notes
During the COVID pandemic, the vaccine approval process went from eight years to a few months. In addition, the FDA has used several expedited approval pathways, starting in the 1990s with HIV treatments and continuing today. On the next two episodes, Tom talks with two leading experts on these various approval pathways, what medications are on the approval fast track, and other considerations regarding expedited approval today.
 
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Clinical Operations and Quality
Vizient
 
Guests:
Jeni Hayes, PharmD, MSPharm, BCPS
Senior Clinical Manager, Pharmacy Outcomes
Center for Pharmacy Practice Excellence
Vizient
 
Steven Lucio, PharmD, BCPS
Senior Principal, Pharmacy Solutions
Center for Pharmacy Practice Excellence
Vizient
 
Show Notes:
[
[
[
[
 
Links | Resources:
To contact Modern Practice: [email protected]
Steven’s email: [email protected]
Jeni’s email: [email protected]
FDA’s accelerated approval update page: Click here
Vizient Pharmacy Market Highlights – Dec. 2022: PMO322_PharmacyMarketOutlook_Highlights.pdf
 
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Android
Google Podcasts
Spotify
Stitcher
RSS Feed